ArticleAmerican journal of translational research2025
Combined assessment of placental growth factor, uterine artery pulsation index, and mean arterial pressure for predicting preeclampsia.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the clinical significance of combined detection of placental growth factor (PLGF), uterine artery pulse index (UTPI), and mean arterial pressure (MAP) in predicting preeclampsia (PE).
methodsA total of 332 pregnant women who underwent regular prenatal check-ups at The Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi) from January 2022 to December 2023 were retrospectively included in this study. Medical histories and laboratory examination data were collected. The participants were divided into a PE group and a normal group based on the occurrence of PE. Clinical data, including MAP, UTPI, and PLGF were recorded between 11 and 13
resultsMultivariate logistic regression analysis identified age, body mass index (BMI), pregnancy associated plasma protein-A (PAPP-A), MAP, UTPI, and PLGF as independent predictors of early pregnancy PE (all P<0.05). The AUC values for age, BMI, PAPP-A, MAP, UTPI, and PLGF were 0.660, 0.669, 0.749, 0.869, 0.781, and 0.943, respectively. The AUC of the combined MAP + UTPI + PLGF model was 0.990 (95% CI: 0.938-0.998), with specificity and sensitivity values of 83.98% and 98.80% respectively. Internal validation showed a mean absolute error (MAE) of 0.012, and the consistency index was 0.99 (95% CI: 0.983-0.997). The AUC for external validation of the prediction model was 0.975 (95% CI 0.955-0.995, P<0.001). Bootstrap analysis (1000 repetitions) using the Hosmer-Lemeshow test showed a good model fit (χ
conclusionAge, BMI, PAPP-A, MAP, UTPI, and PLGF were all effective predictors for early PE. Furthermore, the combined detection of high-risk factors (MAP, UTPI, PLGF) has a high predictive value for PE early in pregnancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.